Position | Company | Period |
---|
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-04-17 | 2024-04-17 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
10.000
-5.6%
38,49384.890 USD |
10.000 -5.6% | 38,49 | 384.890 USD | |
2024-04-17 | 2024-04-16 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
10.000
-5.6%
38,35383.500 USD |
10.000 -5.6% | 38,35 | 383.500 USD | |
2024-03-13 | 2024-03-13 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
10.000
-6.0%
42,27422.730 USD |
10.000 -6.0% | 42,27 | 422.730 USD | |
2024-03-13 | 2024-03-12 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
10.000
-6.0%
41,64416.370 USD |
10.000 -6.0% | 41,64 | 416.370 USD | |
2024-02-28 | 2024-02-28 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
7.471
-4.6%
39,54295.418 USD |
7.471 -4.6% | 39,54 | 295.418 USD | |
2024-02-28 | 2024-02-28 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
2.529
-1.6%
39,56100.045 USD |
2.529 -1.6% | 39,56 | 100.045 USD | |
2024-02-28 | 2024-02-27 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
10.000
-5.9%
39,95399.460 USD |
10.000 -5.9% | 39,95 | 399.460 USD | |
2024-01-18 | 2024-01-17 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
10.000
-6.2%
36,00360.000 USD |
10.000 -6.2% | 36,00 | 360.000 USD | |
2024-01-18 | 2024-01-16 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
10.000
-6.2%
36,00360.000 USD |
10.000 -6.2% | 36,00 | 360.000 USD | |
2023-12-13 | 2023-12-13 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
10.000
-6.2%
40,39403.940 USD |
10.000 -6.2% | 40,39 | 403.940 USD | |
2023-12-13 | 2023-12-12 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
643
-0.4%
40,4726.019 USD |
643 -0.4% | 40,47 | 26.019 USD | |
2023-12-13 | 2023-12-12 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
9.357
-5.8%
39,58370.303 USD |
9.357 -5.8% | 39,58 | 370.303 USD | |
2023-11-16 | 2023-11-14 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
1.708
-1.1%
39,0866.747 USD |
1.708 -1.1% | 39,08 | 66.747 USD | |
2023-11-16 | 2023-11-14 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
8.292
-5.2%
39,08324.043 USD |
8.292 -5.2% | 39,08 | 324.043 USD | |
2023-10-17 | 2023-10-17 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
10.000
-6.2%
36,52365.200 USD |
10.000 -6.2% | 36,52 | 365.200 USD | |
2023-09-19 | 2023-09-19 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
10.000
-6.2%
39,10390.980 USD |
10.000 -6.2% | 39,10 | 390.980 USD | |
2023-08-23 | 2023-08-22 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
8.075
-5.0%
42,41342.437 USD |
8.075 -5.0% | 42,41 | 342.437 USD | |
2023-08-23 | 2023-08-22 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
1.925
-1.3%
42,4181.633 USD |
1.925 -1.3% | 42,41 | 81.633 USD | |
2023-07-19 | 2023-07-18 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
10.000
-6.6%
40,43404.300 USD |
10.000 -6.6% | 40,43 | 404.300 USD | |
2023-06-22 | 2023-06-21 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
10.000
-6.6%
36,00360.000 USD |
10.000 -6.6% | 36,00 | 360.000 USD | |
2023-04-19 | 2023-04-18 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
10.000
-6.6%
36,00360.000 USD |
10.000 -6.6% | 36,00 | 360.000 USD | |
2023-02-28 | 2023-02-27 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
2.984
-2.1%
49,55147.854 USD |
2.984 -2.1% | 49,55 | 147.854 USD | |
2023-02-28 | 2023-02-27 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
7.016
-4.7%
49,55347.629 USD |
7.016 -4.7% | 49,55 | 347.629 USD | |
2023-02-21 | 2023-02-16 |
Halozyme Therapeutics Inc
(HALO)
|
V Verkauf |
2.878
-1.9%
49,26141.770 USD |
2.878 -1.9% | 49,26 | 141.770 USD | |
2023-02-17 | 2023-02-15 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
10.000
-6.5%
48,39483.940 USD |
10.000 -6.5% | 48,39 | 483.940 USD | |
2023-01-18 | 2023-01-17 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
1.122
-0.8%
50,9357.139 USD |
1.122 -0.8% | 50,93 | 57.139 USD | |
2023-01-18 | 2023-01-17 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
8.878
-5.8%
50,40447.451 USD |
8.878 -5.8% | 50,40 | 447.451 USD | |
2022-12-13 | 2022-12-13 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
5.065
-3.2%
58,66297.133 USD |
5.065 -3.2% | 58,66 | 297.133 USD | |
2022-12-13 | 2022-12-13 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
4.935
-3.0%
58,67289.541 USD |
4.935 -3.0% | 58,67 | 289.541 USD | |
2022-11-16 | 2022-11-15 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
3.115
-1.9%
54,14168.643 USD |
3.115 -1.9% | 54,14 | 168.643 USD | |
2022-11-16 | 2022-11-15 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
8
-0.0%
54,61437 USD |
8 -0.0% | 54,61 | 437 USD | |
2022-11-16 | 2022-11-15 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
6.877
-4.0%
54,12372.183 USD |
6.877 -4.0% | 54,12 | 372.183 USD | |
2021-10-01 | 2021-10-01 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
29.450
-16.5%
39,931.175.968 USD |
29.450 -16.5% | 39,93 | 1.175.968 USD | |
2021-07-06 | 2021-07-01 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
40.315
-23.1%
45,701.842.315 USD |
40.315 -23.1% | 45,70 | 1.842.315 USD | |
2021-04-01 | 2021-04-01 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
18.994
-13.4%
42,79812.829 USD |
18.994 -13.4% | 42,79 | 812.829 USD | |
2021-04-01 | 2021-04-01 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
9.695
-6.4%
42,11408.208 USD |
9.695 -6.4% | 42,11 | 408.208 USD | |
2021-03-01 | 2021-03-01 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
6.530
-5.0%
46,26302.061 USD |
6.530 -5.0% | 46,26 | 302.061 USD | |
2021-03-01 | 2021-03-01 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
11.794
-8.4%
45,56537.303 USD |
11.794 -8.4% | 45,56 | 537.303 USD | |
2020-12-21 | 2020-12-21 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
600
-0.5%
43,2525.951 USD |
600 -0.5% | 43,25 | 25.951 USD | |
2020-12-21 | 2020-12-21 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
11.400
-8.5%
42,54484.967 USD |
11.400 -8.5% | 42,54 | 484.967 USD | |
2020-11-20 | 2020-11-20 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
7.889
-5.5%
39,04307.955 USD |
7.889 -5.5% | 39,04 | 307.955 USD | |
2020-11-20 | 2020-11-20 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
4.111
-2.8%
38,24157.221 USD |
4.111 -2.8% | 38,24 | 157.221 USD | |
2020-10-20 | 2020-10-20 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
12.000
-7.6%
30,43365.148 USD |
12.000 -7.6% | 30,43 | 365.148 USD | |
2020-09-21 | 2020-09-21 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
12.000
-7.0%
26,91322.884 USD |
12.000 -7.0% | 26,91 | 322.884 USD | |
2020-08-20 | 2020-08-20 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
12.000
-6.6%
28,30339.564 USD |
12.000 -6.6% | 28,30 | 339.564 USD | |
2020-07-20 | 2020-07-20 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
12.000
-6.2%
29,01348.072 USD |
12.000 -6.2% | 29,01 | 348.072 USD | |
2020-05-21 | 2020-05-20 |
Halozyme Therapeutics Inc
(HALO)
|
GV Geplanter Verkauf |
21.387
-10.8%
23,80509.075 USD |
21.387 -10.8% | 23,80 | 509.075 USD |